Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IINN
#3817
Inspira Technologies Oxy B.H.N. Ltd. Ordinary Shares
0.5
8
0.00%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
0.00%
Monatliche Änderung
-27.50%
6 month change
-49.57%
Jahresänderung
-30.12%
Vorheriger Schlusskurs
0.5
8
Open
0.5
8
Bid
Ask
Low
0.5
8
High
0.5
8
Volumen
4
Märkte
Aktien
Gesundheitswesen
IINN
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
24.25 M
61.33 M
Valuation ratios
Enterprise value
19.63 M
85.8 M
Price to earnings ratio
-1.7
—
Price to sales ratio
—
—
Price to cash flow ratio
-2.01
—
Price to book ratio
4.37
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
-0.05
—
Return on equity %
-0.09
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
1.89
—
Current ratio
2.02
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
-0.02
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
0.31
—
Net current asset value per share
0.37
—
Tangible book value per share
0.23
—
Working capital per share
0.19
—
Book value per share
0.23
—
Nachrichten
Inspira Technologies股价在公布液体活检扩张计划后上涨
Inspira Technologies stock rises after outlining liquid biopsy expansion plan
Inspira Technologies 公布液体活检收购战略
Inspira Technologies outlines liquid biopsy acquisition strategy
Inspira Technologies重申4950万美元采购订单
Inspira Technologies reaffirms $49.5 million in purchase orders
Inspira Technologies secures Japanese patent for dual lumen cannula
Inspira Technologies计划于2025年12月30日举行年度和特别股东大会
Inspira Technologies schedules annual and extraordinary shareholder meeting for December 30
Inspira completes clinical study for HYLA blood sensor with high accuracy
Inspira Technologies股价在提交阿联酋监管申请后上涨
Inspira Technologies stock rises after UAE regulatory submission